✦ LIBER ✦

2 Acquired factor V inhibitors

✍ Scribed by Paul Knöbl; Klaus Lechner

Book ID: 114308040
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 928 KB
Volume: 11
Category: Article
ISSN: 0950-3536
DOI: 10.1016/s0950-3536(98)80050-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired factor V inhibitor

✍ P. P. G. Teh; G. Grigoriadis; H. Salem 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Acquired factor V inhibitors: a systemat

Acquired factor V inhibitors: a systematic review

✍ Massimo Franchini; Giuseppe Lippi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 242 KB

Acquired factor V inhibitor in systemic

Acquired factor V inhibitor in systemic vasculitis

✍ Chu-Oi CIANG; Moon-Ho LEUNG 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 158 KB

Acquired factor V inhibitor complicating

Acquired factor V inhibitor complicating warfarin therapy

✍ Benjamin Gartrell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Acquired factor V inhibitor after liver

Acquired factor V inhibitor after liver transplantation

✍ Sun, Li-Ying; Zhu, Zhi-Jun; Zeng, Zhi-Gui; Qu, Wei; Zhang, Lei; Tian, Meng-Su; S 📂 Article 📅 2014 🏛 Elsevier 🌐 French ⚖ 508 KB

Multimodality therapy of an acquired fac

Multimodality therapy of an acquired factor V inhibitor

✍ Fu, Yang-Xin; Kaufman, Richard; Rudolph, Amy E.; Collum, Steven E.; Blinder, Mor 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Acquired inhibitors of factor V are rare causes of clinlcai bleeding, whose severity ranges from mild to iife-threatening. Optimal treatment of patients with factor V inhibitors is uncertain. We report on our successful treatment approach in a patient with spontaneous, life-threatening intracraniai